NanoGroup S.A. (WSE:NNG)
2.400
-0.040 (-1.64%)
Oct 9, 2026, 4:59 PM CET
NanoGroup Revenue
NanoGroup had revenue of 3.05M PLN in the quarter ending June 30, 2026, with 1,819.50% growth. This brings the company's revenue in the last twelve months to 2.89M, up 1,718.35% year-over-year. That makes NanoGroup the 44,019th largest company in the world by revenue and 488th in Poland.
Revenue (ttm)
2.89M
Revenue Growth
+1,718.35%
P/S Ratio
35.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
102.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 2.10K | 81.00 | 4.01% |
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 257.23M |
| Ryvu Therapeutics | 83.94M |
| Synthaverse | 48.76M |
| Mabion | 17.61M |
| Molecure | 4.86M |
| Urteste | 2.77M |
| genXone | 2.48M |
| Captor Therapeutics Spolka Akcyjna | 2.01M |